Patents by Inventor Frederick C. Beddingfield

Frederick C. Beddingfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS
    Publication number: 20160279143
    Abstract: The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
    Type: Application
    Filed: November 12, 2015
    Publication date: September 29, 2016
    Inventors: Gurpreet Ahluwalia, Frederick C. Beddingfield, Sydney G. Edwards, Scott M. Whitcup
  • Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
    Patent number: 9226931
    Abstract: The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: January 5, 2016
    Assignee: Allergan, Inc.
    Inventors: Gurpreet Ahluwalia, Frederick C. Beddingfield, Sydney G. Edwards, Scott M. Whitcup
  • Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
    Patent number: 9216183
    Abstract: The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: December 22, 2015
    Assignee: Allergan, Inc.
    Inventors: Gurpreet Ahluwalia, Frederick C. Beddingfield, Sydney Edwards, Scott M. Whitcup
  • TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS
    Publication number: 20140221493
    Abstract: The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
    Type: Application
    Filed: April 11, 2014
    Publication date: August 7, 2014
    Applicant: ALLERGAN, INC.
    Inventors: GURPREET AHLUWALIA, FREDERICK C. BEDDINGFIELD, SYDNEY EDWARDS, SCOTT M. WHITCUP
  • TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS
    Publication number: 20140194450
    Abstract: The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
    Type: Application
    Filed: January 10, 2013
    Publication date: July 10, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Gurpreet Ahluwalia, Frederick C. Beddingfield, Sydney G. Edwards, Scott M. Whitcup
  • TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS
    Publication number: 20140187642
    Abstract: The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
    Type: Application
    Filed: March 6, 2014
    Publication date: July 3, 2014
    Applicant: ALLERGAN, INC.
    Inventors: Gurpreet Ahluwalia, Frederick C. Beddingfield, Sydney G. Edwards, Scott M. Whitcup
  • Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
    Patent number: 8758733
    Abstract: The present invention is directed to compositions and methods for the treatment of post-chemotherapeutic hypotrichosis. More specifically, the present invention is directed to the use of compositions comprising bimatoprost for the treatment of post-chemotherapeutic hypotrichosis which may be applied before, during and after receiving chemotherapeutic treatment.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: June 24, 2014
    Assignee: Allergan, Inc.
    Inventors: Gurpreet Ahluwalia, Frederick C. Beddingfield, Sydney G. Edwards, Scott M. Whitcup
  • DEVICES, COMPOSITIONS AND METHODS UTILIZING EP4 AND EP2 RECEPTOR AGONISTS FOR PREVENTING, REDUCING OR TREATING CAPSULAR CONTRACTURE
    Publication number: 20120259413
    Abstract: Provided are devices, compositions and methods utilizing EP4 and EP2 receptor agonists for preventing, reducing, or treating capsular contracture occurring in response to the implantation of breast prostheses.
    Type: Application
    Filed: July 29, 2011
    Publication date: October 11, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Guang-Liang Jiang, Wha Bin Im, Gurpreet Ahluwalia, Frederick C. Beddingfield, Larry A. Wheeler, Scott M. Whitcup
  • COMPOUNDS AND METHODS FOR SKIN REPAIR
    Publication number: 20120136011
    Abstract: The disclosure provides compositions and methods for treating a skin blemish. The compositions comprise a therapeutically effective amount of a compound useful for treating skin blemishes such as wounds, scars and wrinkles.
    Type: Application
    Filed: July 29, 2011
    Publication date: May 31, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Guang L. Jiang, Wha-Bin Im, Frederick C. Beddingfield, Larry A. Wheeler, Scott M. Whitcup, Robert M. Burk
  • COMBINATION OF DAPSONE WITH OTHER ANTI-ACNE AGENTS
    Publication number: 20110305747
    Abstract: A composition suitable for topical application that contains at least two active ingredients, one of these being dapsone and one selected from the group consisting of adapalene, tazarotene and treinion for the effective treatment of acne and other dermatological conditions.
    Type: Application
    Filed: January 25, 2011
    Publication date: December 15, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Gurpreet Ahluwalia, Kevin S. Warner, Haigang Chen, Meidong Yang, Jeffrey R. Ehrhardt, Frederick C. Beddingfield
  • KIT AND COMPOSITION FOR EYELASH GROWTH
    Publication number: 20100204335
    Abstract: The invention provides a kit for enhancing the appearance of eyelashes, comprising an eyelash enhancing composition and delivery system. The eyelash enhancing composition comprises an effective amount of 0.03% bimatoprost. The delivery system comprises a plurality of applicator brushes designed to deliver a fraction of 1-drop bimatoprost dose to the target area.
    Type: Application
    Filed: November 30, 2009
    Publication date: August 12, 2010
    Applicant: ALLERGAN, INC.
    Inventors: Frederick C. Beddingfield, John G. Walt, Christine Somogyi, Chetan Pujara, Julie Albright
  • Clinical Assessment Scales and Methods
    Publication number: 20100121223
    Abstract: Disclosed herein are scales for assessing eyelash prominence. The scales comprise rows or columns of photographs corresponding to different categories of eyelash prominence.
    Type: Application
    Filed: October 27, 2009
    Publication date: May 13, 2010
    Applicant: ALLERGAN, INC.
    Inventors: Sandra L. Friborg, Frederick C. Beddingfield, Christine Somogyi, John C. Lue